SynthesisEuropean journal of clinical nutrition2020
Dose-response associations of maternal height and weight with small for gestational age: a meta-analysis.
Synthesis in European journal of clinical nutrition, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Association of high maternal blood alpha-fetoprotein level with risk of delivering small for gestational age: a meta-analysis.Pediatric research · 2021Pooled it
- Prediction Model of Late Fetal Growth Restriction with Machine Learning Algorithms.Life (Basel, Switzerland) · 2024Article
- Difference in risk of preterm and small-for-gestational-age birth depending on maternal occupations in Japan.BMC research notes · 2023Article
- Prediction of late-onset fetal growth restriction by umbilical artery velocities at 37 weeks of gestation: a cross-sectional study.BMJ open · 2022Article
- Novel sex-specific influence of parental factors on small-for-gestational-age newborns.Scientific reports · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND/
objectivesSmall for gestational age (SGA) may be associated with increased rates of mortality and morbidity not only during the infantile period but also in later life. This study was performed to determine the dose-response relationships of maternal height and weight with risk of SGA. SUBJECTS/
methodsDose-response meta-analyses were performed to summarize adjusted relative risks of SGA per 1-cm in maternal height and 1-kg increase in weight (linear model) and for varying levels relative to 160 cm in height and 55 kg in weight (nonlinear model). The adjustments for potential confounders were made using the Hamling method. Eight databases, including PubMed (MEDLINE), were searched. Study quality was assessed using the Newcastle-Ottawa scale (NOS).
resultsTotals of 117,114 and 13,049 subjects were extracted from high-quality studies (e.g., NOS score ≥ 8) to evaluate maternal height (n = 7) and weight (n = 3), respectively. Corresponding to P for nonlinearity (P < 0.05), the dose-response relationships were nonlinear rather than linear. The nonlinear model showed that maternal height and weight were significantly and inversely associated with the risk of SGA, regardless of the levels below or above their means (i.e., 160 cm or 55 kg, respectively).
conclusionsSGA risk may be reduced by increasing maternal height and weight.
Indexed as
Identifiers
31076655What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.